http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021128512-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36310ab39fe797510fbf5c0408149b4f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-27
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
filingDate 2021-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed0883c99414948f58ea3ee19b6c23af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecd3b2d3bba88f1a1dd4e6bdb48afe6f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a48126798911423d95900d4b5578c0e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e27b963454b4c319426f2f57237ff53a
publicationDate 2021-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2021128512-A1
titleOfInvention Use of histone deacetylase inhibitors for the care of philadelphia-negative myeloproliferative syndromes
abstract Method of treating Philadelphia-negative myeloproliferative syndromes in a patient suffering therefrom by administering to the patient diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphthalen-2-yl-methyl]-ammonium chloride, or other pharmaceutically acceptable salts and/or solvates, in a daily dosage amount of from 50 to 100 mg per patient.
priorityDate 2008-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396790
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403801
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6942
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID109644000
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID433759
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID549637
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373339
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100689317
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID457553
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4328717
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID464259
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423831
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID738624
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227752272
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID81782
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID574282
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8841
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID15183
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID504287
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID15978
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID432017
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3065
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID44446
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID404126
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID404125
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID478040
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID15181
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159110088
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID405790
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450216269
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87259244
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID297893
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID490325
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID393965
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400055
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395506
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID84578
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID449517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4842
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID192302
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID487309
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID20652
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373961
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25712
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6646
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID38565
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281237
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396054
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396991
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3458
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311

Total number of triples: 83.